EP-1356: SBRT benefit in oligometastatic prostate cancer patients detected by [18 F]fluoromethylcholine PET/CT. (May 2017) - Bouman-Wammes, E.; Van Dodewaard-de Jong, J.M.; Dahele, M.; Cysouw, M.C.F.; Hoekstra, O.S.; Piet, A.H.M.; Van den Eertwegh, A.J.M.; Verheul, H.M.W.; Oprea-Lager, D.E.; V.M.H